Literature DB >> 15837791

Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.

Linda Wooldridge1, Hugo A van den Berg, Meir Glick, Emma Gostick, Bruno Laugel, Sarah L Hutchinson, Anita Milicic, Jason M Brenchley, Daniel C Douek, David A Price, Andrew K Sewell.   

Abstract

The off-rate (k(off)) of the T cell receptor (TCR)/peptide-major histocompatibility complex class I (pMHCI) interaction, and hence its half-life, is the principal kinetic feature that determines the biological outcome of TCR ligation. However, it is unclear whether the CD8 coreceptor, which binds pMHCI at a distinct site, influences this parameter. Although biophysical studies with soluble proteins show that TCR and CD8 do not bind cooperatively to pMHCI, accumulating evidence suggests that TCR associates with CD8 on the T cell surface. Here, we titrated and quantified the contribution of CD8 to TCR/pMHCI dissociation in membrane-constrained interactions using a panel of engineered pMHCI mutants that retain faithful TCR interactions but exhibit a spectrum of affinities for CD8 of >1,000-fold. Data modeling generates a "stabilization factor" that preferentially increases the predicted TCR triggering rate for low affinity pMHCI ligands, thereby suggesting an important role for CD8 in the phenomenon of T cell cross-reactivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837791      PMCID: PMC2441837          DOI: 10.1074/jbc.M500555200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation.

Authors:  Phillip D Holler; David M Kranz
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

2.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

3.  Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.

Authors:  Valérie Dutoit; Philippe Guillaume; Maha Ayyoub; Charles S Hesdorffer; Immanuel F Luescher; Danila Valmori
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

4.  High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.

Authors:  Jennifer Buslepp; Samantha E Kerry; Doug Loftus; Jeffrey A Frelinger; Ettore Appella; Edward J Collins
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

5.  The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.

Authors:  Sarah L Hutchinson; Linda Wooldridge; Sabrina Tafuro; Bruno Laugel; Meir Glick; Jonathan M Boulter; Bent K Jakobsen; David A Price; Andrew K Sewell
Journal:  J Biol Chem       Date:  2003-04-15       Impact factor: 5.157

6.  Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis.

Authors:  Philippe Guillaume; Daniel F Legler; Nicole Boucheron; Marie-Agnès Doucey; Jean-Charles Cerottini; Immanuel F Luescher
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

Review 7.  Molecular interactions mediating T cell antigen recognition.

Authors:  P Anton van der Merwe; Simon J Davis
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

8.  High avidity antigen-specific CTL identified by CD8-independent tetramer staining.

Authors:  Ed Man-Lik Choi; Ji-Li Chen; Linda Wooldridge; Mariolina Salio; Anna Lissina; Nikolai Lissin; Ian F Hermans; Jonathan D Silk; Fareed Mirza; Michael J Palmowski; P Rod Dunbar; Bent K Jakobsen; Andy K Sewell; Vincenzo Cerundolo
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

9.  CD3 delta establishes a functional link between the T cell receptor and CD8.

Authors:  Marie-Agnès Doucey; Laurence Goffin; Dieter Naeher; Olivier Michielin; Petra Baumgärtner; Philippe Guillaume; Ed Palmer; Immanuel F Luescher
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

10.  Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.

Authors:  Mikaël J Pittet; Verena Rubio-Godoy; Gilles Bioley; Philippe Guillaume; Pascal Batard; Daniel Speiser; Immanuel Luescher; Jean-Charles Cerottini; Pedro Romero; Alfred Zippelius
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  92 in total

1.  Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions.

Authors:  Naeem Khan; Mark Cobbold; Joanne Cummerson; Paul A H Moss
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

Review 2.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

3.  The T cell receptor's alpha-chain connecting peptide motif promotes close approximation of the CD8 coreceptor allowing efficient signal initiation.

Authors:  Michel Mallaun; Dieter Naeher; Mark A Daniels; Pia P Yachi; Barbara Hausmann; Immanuel F Luescher; Nicholas R J Gascoigne; Ed Palmer
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

4.  Expansion of Simian Immunodeficiency Virus (SIV)-Specific CD8 T Cell Lines from SIV-Naive Mauritian Cynomolgus Macaques for Adoptive Transfer.

Authors:  Mariel S Mohns; Justin M Greene; Brian T Cain; Ngoc H Pham; Emma Gostick; David A Price; David H O'Connor
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

5.  Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.

Authors:  Timothy T Spear; Yuan Wang; Kendra C Foley; David C Murray; Gina M Scurti; Patricia E Simms; Elizabeth Garrett-Mayer; Lance M Hellman; Brian M Baker; Michael I Nishimura
Journal:  Cancer Immunol Immunother       Date:  2017-06-20       Impact factor: 6.968

6.  Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.

Authors:  Lorraine Yeo; Alyssa Woodwyk; Sanjana Sood; Anna Lorenc; Martin Eichmann; Irma Pujol-Autonell; Rosella Melchiotti; Ania Skowera; Efthymios Fidanis; Garry M Dolton; Katie Tungatt; Andrew K Sewell; Susanne Heck; Alka Saxena; Craig A Beam; Mark Peakman
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

7.  Modulation of MHC binding by lateral association of TCR and coreceptor.

Authors:  Karlo Perica; Joan Glick Bieler; Michael Edidin; Jonathan Schneck
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

Review 8.  The molecular determinants of CD8 co-receptor function.

Authors:  David K Cole; Bruno Laugel; Mathew Clement; David A Price; Linda Wooldridge; Andrew K Sewell
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

9.  Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Authors:  Rui Wang; Kannan Natarajan; David H Margulies
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

10.  Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Authors:  Linda Wooldridge; Anna Lissina; Jonathan Vernazza; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Fareed Mirza; P Rod Dunbar; Jonathan M Boulter; Meir Glick; Vincenzo Cerundolo; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.